Back
UBS ETRACS Crude Oil Shs Covrd Call ETN Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
37
USOI
UBS ETRACS Crude Oil Shs Covrd Call ETN
Last Price:
$46.84
Seasonality Move:
-1.54%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
37
UBS ETRACS Crude Oil Shs Covrd Call ETN (USOI)
is a Sell
Is UBS ETRACS Crude Oil Shs Covrd Call ETN a Buy, Sell or Hold?
-
The current UBS ETRACS Crude Oil Shs Covrd Call ETN [USOI] share price is $46.90. The Score for USOI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
USOI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USOI Stock Price Chart
What is UBS ETRACS Crude Oil Shs Covrd Call ETN's stock price today?
-
The UBS ETRACS Crude Oil Shs Covrd Call ETN share price today is $46.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USOI is experiencing selling pressure, which indicates risk of future bearish movement.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $39.6400Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
USOI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.43 | Buy |
| Relative Strength Index (14 RSI): | 42.33 | Sell |
| Chaikin Money Flow: | -168352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.13 - 48.79) | Sell |
| Bollinger Bands (100): | (48.23 - 51.55) | Sell |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.28 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -583105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9202 - 36.9202) | Buy |
| Bollinger Bands (100): | (20.9405 - 34.5405) | Buy |
USOI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.03 | Sell |
| 20-day SMA: | 47.92 | Sell |
| 50-day SMA: | 48.52 | Sell |
| 200-day SMA: | 52.73 | Sell |
| 8-day EMA: | 36.77 | Buy |
| 20-day EMA: | 21.31 | Buy |
| 50-day EMA: | 10.07 | Buy |
| 200-day EMA: | 2.75 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 35.4 | Buy |
| 50-day SMA: | 33.69 | Buy |
| 200-day SMA: | 22.3 | Buy |
| 8-day EMA: | 30.99 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 8.93 | Buy |
| 200-day EMA: | 2.46 | Buy |
UBS ETRACS Crude Oil Shs Covrd Call ETN Earnings Growth & USOI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
UBS ETRACS Crude Oil Shs Covrd Call ETN Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||